Earnings Labs
Inhibikase Therapeutics, Inc. logo

Inhibikase Therapeutics, Inc. (IKT)

NASDAQ·Healthcare·Biotechnology

$1.88

-0.79%

Mkt Cap $134.20M

Mkt Cap

$134.20M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$0.49

EPS — Estimate vs Actual